4-(4-Methyl-pyridin-2-yloxy)-piperidine-1-carboxylic acid tert-butyl ester
- $240 - $496.72
- Product name: 4-(4-Methyl-pyridin-2-yloxy)-piperidine-1-carboxylic acid tert-butyl ester
- CAS: 944390-87-8
- MF: C16H24N2O3
- MW: 292.37
- EINECS:
- MDL Number:MFCD09862001
- Synonyms:4-(4-Methyl-pyridin-2-yloxy)-piperidine-1-carboxylic acid tert-butyl ester;4-(4-methylpyridin-2-yloxy)-N-Boc-piperidine;1-Piperidinecarboxylic acid, 4-[(4-methyl-2-pyridinyl)oxy]-, 1,1-dimethylethyl ester
3 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Chemenu
- Crysdot
Package
- 5MG
- 500mg
- 1g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0238243
- Product descriptionTERT-BUTYL-4-(4-METHYL-PYRIDIN-2-YLOXY)-PIPERIDINE-1-CARBOXYLATE 95.00%
- Packaging5MG
- Price$496.72
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM301371
- Product descriptiontert-butyl4-((4-methylpyridin-2-yl)oxy)piperidine-1-carboxylate 95%
- Packaging500mg
- Price$240
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11007145
- Product descriptiontert-Butyl4-((4-methylpyridin-2-yl)oxy)piperidine-1-carboxylate 95+%
- Packaging1g
- Price$482
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | CHM0238243 | TERT-BUTYL-4-(4-METHYL-PYRIDIN-2-YLOXY)-PIPERIDINE-1-CARBOXYLATE 95.00% | 5MG | $496.72 | 2021-12-16 | Buy |
Chemenu | CM301371 | tert-butyl4-((4-methylpyridin-2-yl)oxy)piperidine-1-carboxylate 95% | 500mg | $240 | 2021-12-16 | Buy |
Crysdot | CD11007145 | tert-Butyl4-((4-methylpyridin-2-yl)oxy)piperidine-1-carboxylate 95+% | 1g | $482 | 2021-12-16 | Buy |
Properties
Boiling point :399.1±42.0 °C(Predicted)
Density :1.108±0.06 g/cm3(Predicted)
pka :4.44±0.20(Predicted)
Density :1.108±0.06 g/cm3(Predicted)
pka :4.44±0.20(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|